Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer-Reference-Cited by-同舟云学术

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

Published:2011-10 Issue:15 Volume:47 Page:2273-2281
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

von Minckwitz Gunter,Schwedler Kathrin,Schmidt Marcus,Barinoff Jana,Mundhenke Christoph,Cufer Tanja,Maartense Eduard,de Jongh Felix E.,Baumann Klaus H.,Bischoff Joachim,Harbeck Nadia,Lück Hans-Joachim,Maass Nicolai,Zielinski Christoph,Andersson Michael,Stein Robert C.,Nekljudova Valentina,Loibl Sibylle

Funder

UCLH/UCL Comprehensive Biomedical Research Centre

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference13 articles.

1. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review;Dawood;J Clin Oncol,2010

2. Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer;Bartsch;J Clin Oncol,2007

3. Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories;Gelmon;Clin Breast Cancer,2004

4. Jackisch C, Eustermann H, Schoenegg W, et al. Clinical use of trastuzumab (Herceptin) in metastatic breast cancer (MBC) in Germany from 2001 to 2006. San Antonio Breast Cancer Symposium (SABCS); 2007.

5. Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression;Tripathy;J Clin Oncol,2004

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Trastuzumab Emtansine in treating human epidermal growth factor receptor 2-positive metastatic breast cancer in Chinese population: a real-world multicenter study;Frontiers in Medicine;2024-04-29

2. Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08);Targeted Oncology;2024-01

3. Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape;Current Oncology;2023-12-26

4. Trastuzumab Biosimilar (HLX02), Pertuzumab Plus Chemotherapy in Patients with HER2-Positive Metastatic Breast Cancer after Progression of Trastuzumab: A Prospective, Phase II Study;Cancer Research and Treatment;2023-12-20

5. Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer;Current Treatment Options in Oncology;2023-10-25